Clinitech Laboratory (BOM:544220) ROCE %: 5.46% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544220 Clinitech Laboratory Ltd BOM:544220
38 GF Score
Price ₹37.00
! 6 Warning Signs
View Full Analysis

What is Clinitech Laboratory ROCE %?

Clinitech Laboratory BOM:544220 -7.50% 38 ROCE % is 5.46% as of Mar. 2026. GuruFocus rates BOM:544220 with a GF Score™ of 38/100. The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Clinitech Laboratory's annualized ROCE % for the quarter that ended in Mar. 2026 was 5.46%.

Clinitech Laboratory  (BOM:544220) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Clinitech Laboratory ROCE % Related Terms

Clinitech Laboratory ROCE % Historical Data

* Premium members only.

The historical data trend for Clinitech Laboratory's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clinitech Laboratory ROCE % Chart

Clinitech Laboratory Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial 34.66 27.93 14.00 9.38 6.98

Clinitech Laboratory Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only 27.52 8.62 6.65 8.59 5.46
BOM:544220
38GF Score
Clinitech Laboratory Ltd BOM:544220
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clinitech Laboratory ROCE % Calculation

Clinitech Laboratory's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=6.654/( ( (107.125 - 16.834) + (111.787 - 11.346) )/ 2 )
=6.654/( (90.291+100.441)/ 2 )
=6.654/95.366
=6.98 %

Clinitech Laboratory's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=5.346/( ( (111.272 - 16.028) + (111.787 - 11.346) )/ 2 )
=5.346/( ( 95.244 + 100.441 )/ 2 )
=5.346/97.8425
=5.46 %

(1) Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 5.46% mean?
Clinitech Laboratory (BOM:544220) has a ROCE % of 5.46% as of Mar. 2026.
Is Clinitech Laboratory's ROCE % too high?
Clinitech Laboratory's current ROCE % is 5.46%. Overall, Clinitech Laboratory has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Clinitech Laboratory's ROCE % compare to TMO and DHR?
Clinitech Laboratory's ROCE % of 5.46% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Diagnostics & Research company?
A good ROCE % depends on the Medical Diagnostics & Research industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Clinitech Laboratory's current ROCE % is 5.46%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clinitech Laboratory stock overvalued right now?
Clinitech Laboratory (BOM:544220) has a current ROCE % of 5.46%. The current ROCE % is 5.46%. Clinitech Laboratory's overall GF Score™ is 38/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Clinitech Laboratory (BOM:544220), the current ROCE % is 5.46% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Clinitech Laboratory Business Description

Address AL-1/545 and 546, Sector 16, Opposite Radhikabai Meghe Vidyalaya, Airoli, Navi Mumbai, MH, IND, 400708
Clinitech Laboratory Ltd is an Indian diagnostic and healthcare services provider company. It operates a network of diagnostic centers in Thane and Navi Mumbai and offers various medical tests across multiple specialties, including biochemistry, immunology, hematology, molecular biology, serology, microbiology, and histopathology. It serves individual patients as well as corporate clients, aiming to provide affordable and comprehensive diagnostic solutions.
38GF Score

Get the complete analysis for BOM:544220

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹37.00
Price